202 In vivo and in vitro characterization of AIM ACT, a novel nanoparticle-based technology, expanded MART-1 specific T cells

• Mathias Oelke,
• Emily Lu,
• Ruipeng Wang,
• Lauren Suarez,
• Pratima Kunwar,
• Daniel Dembrow,
• Sojung Kim

Affiliations

Mathias Oelke

Aff1 grid.21107.350000000121719311Johns Hopkins School of Medicine Baltimore Maryland United States

Emily Lu

2Massachusetts Department of Public Health, Boston, MA, USA

Ruipeng Wang

NeImmune, Gaithersburg, MD, USA

Lauren Suarez

NeImmune, Gaithersburg, MD, USA

Pratima Kunwar

NeImmune, Gaithersburg, MD, USA

Daniel Dembrow

NeImmune, Gaithersburg, MD, USA

Sojung Kim

NeImmune, Gaithersburg, MD, USA